Articles

Office-to-residential conversions are facing obstacles under White House program, developers say

Property owners say time is running out as the real-estate industry’s finances grow more dire, and claim the federal government needs to remove funding obstacles preventing conversion projects from coming to fruition.

Amazon CEO Andy Jassy’s $9 million stock sale this week may be cause for caution

Recent transactions by both Amazon’s chief executive and a board member seem linked to the stock’s price, says an expert.

Wegovy gets FDA approval to reduce risk of heart issues in overweight adults

The FDA on Friday said it approved Novo Nordisk’s popular weight-loss drug Wegovy to reduce the risk of severe heart issues in overweight or obese adults.

Bitcoin bulls eye $100,000 as the next level before its halving. Here’s what’s driving the crypto’s rally.

Some crypto bulls are now eyeing $100,000 as bitcoin’s next level, after the leading cryptocurrency on Friday briefly topped $70,000 for the first time in its history.

Complaints about stock market’s ‘bad breadth’ are overblown. Here’s why.

Market gurus love to complain about the fact that the performance of indexes like the S&P 500 is increasingly being driven by a small cadre of megacap stocks.

Here’s why gold, bitcoin and stocks are all hitting new highs

It may be surprising to see safe-haven gold score record highs at generally the same time as riskier assets such as bitcoin, U.S. stock indexes, and other global stock benchmarks. Here’s what’s going on.

SoFi’s stock had a historic drop earlier this week. What if it was misguided?

SoFi’s bid to raise capital sparked a record one-day selloff in its shares earlier this week. One analyst thinks Wall Street may have misunderstood the impact of that financial move.

Why Reddit is ‘walking a tightrope’ with its IPO

The social-media platform could find itself at odds with its loyal user base as it strives for profitability, said Jon Keidan, founder and managing partner of venture fund Torch Capital.

Viking Therapeutics faces higher bar for oral weight-loss drug after strong readout from rival

Viking Therapeutics Inc.’s stock fell 5.6% Friday, in a pullback from recent highs, after strong data from Novo Nordisk on an oral version of its weight-loss drug raised the competitive bar for Viking, which is expected to release data from its oral-drug trial late this quarter.

Biden said ‘working people’ pay more into Social Security than millionaires and billionaires — do you? 

‘It’s not fair,’ the president said during the State of the Union address

Nvidia’s stock heads for dramatic reverse lower not seen in over two years

Nvidia’s stock has been nearly invincible lately and initially seemed on track to log its seventh session in a row of gains — before a dramatic reversal lower.

My mother signed her house over to my brother before she died. He refinanced it and sold the contents. Are we entitled to a share of the proceeds?

“I wrote him a check for $5,000 15 years ago because my mother would have died on the spot if she had been evicted from her home.”
1 1,587 1,588 1,589 1,590 1,591 2,523